Infection and Immunity, July 2000, p. 4264-4273, Vol. 68, No. 7
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

INSERM U4471 and CNRS UMR 8527,3 Institut de Biologie de Lille, Institut Pasteur de Lille, Lille, and INSERM E9922, Groupe Hospitalier Bichat-Claude Bernard, Paris,2 France
Received 13 September 1999/Returned for modification 1 November 1999/Accepted 7 March 2000
| |
ABSTRACT |
|---|
|
|
|---|
It has previously been reported that inhibition of delayed-type
hypersensitivity-mediating functions of T cells during mycobacterial infection in mice is haplotype dependent. In the present study, we show
that Mycobacterium bovis BCG infection induced, in
susceptible C57BL/6 and BALB/c mice but not in resistant C3H/HeJ and
DBA/2 mice, an important splenomegaly. An in vitro defect in T-cell proliferation in response to T-cell receptor (TCR) stimulation with
mitogens or anti-CD3 antibodies was associated with enhanced levels of
CD4+ and CD8+ T-cell apoptosis in susceptible
but not in resistant mice 2 weeks after infection. Further
investigations of C57BL/6 and C3H/HeJ mice revealed that in vivo
splenomegaly was associated with destruction of the lymphoid tissue
architecture, liver cellular infiltrates, and increased numbers of
apoptotic cells in both spleen and liver tissue sections. Infection of
C57BL/6 mice but not of C3H/HeJ mice induced massive production of
tumor necrosis factor alpha (TNF-
) in serum, as well as an increase
in Fas and Fas ligand (FasL) expression in T cells. In vitro addition
of neutralizing anti-TNF-
antibodies led to a significant reduction
in CD3-induced T-cell apoptosis of both CD4+ and
CD8+ T cells of C57BL/6 mice, while the blockade of
Fas-FasL interactions reduced apoptosis only in CD4+ but
not in CD8+ T cells. Together, these results suggest that
TNF-
and Fas-FasL interactions play a role in the activation-induced
cell death (AICD) process associated with a defect in T-cell
proliferation of the susceptible C57BL/6 mice. T-cell death by
apoptosis may represent one of the important components of the
ineffective immune response against mycobacterium-induced
immunopathology in susceptible hosts.
| |
INTRODUCTION |
|---|
|
|
|---|
Development of tuberculosis is often associated with a depression of cellular immunity, as shown by a loss of the tuberculin skin test reaction (17), a decrease in interleukin-2 (IL-2) secretion and in IL-2 receptor (IL-2R) expression (48), and a reduction in cell proliferation (32). In pulmonary tuberculosis, the predominant form of the disease, 17 to 25% of the patients are unresponsive to purified protein derivative (PPD) skin testing (7) and 40 to 60% of the patients have low blastogenic responses to PPD (24).
Immunosuppressive features are also manifest in some but not all strains of mycobacterium-infected mice (36). Strain variation in resistance to mycobacterial infections among mice has been noted for several decades. Some mouse strains are susceptible (bcgs) and others are resistant (bcgr) to various mycobacterial infections including those with Mycobacterium bovis BCG. Resistance or susceptibility to infection with intracellular pathogens such as Salmonella and Mycobacterium is controlled by the natural resistance-associated macrophage protein (Nramp1) gene on chromosome 1, which influences the rate of intracellular replication of these parasites in macrophages (15, 51). Kaledin et al. (18) observed that 4 weeks after intravenous inoculation of BCG, the number of viable bacilli recovered from the spleens of C57BL/6 mice was more than 20 times greater than the number recovered from a resistant mouse strain. Lagrange and Hurtrel (27) showed that the BCG, when injected intravenously, multiplied markedly in the spleens of C57BL/6 mice. No multiplication occurred in resistant mice, and the bacilli were steadily eliminated from the spleen. The innate susceptibility of mice to mycobacterial infection seemed to be expressed very early in the course of the host-parasite interaction. Resistance appears to involve macrophages able to limit the growth of the bacteria and subsequently eliminate them (44). Thus, it has been proposed that resistant mice are able to prevent bacterial growth without the need for a cellular response whereas susceptible mice will eventually control bacterial growth by the acquisition of cellular immunity (38). More recently, however, it has been shown that there is a selective regulation of costimulatory molecules on the surface of infected macrophages (42). It was found that B7 was down-regulated while ICAM-1 was up-regulated in susceptible BALB/c mice but not in resistant C3H/HeJ mice and that these changes resulted in the inhibition of delayed-type hypersensitivity-mediating functions of T helper cells from BALB/c mice. This depressed T-helper-cell function concerns not only mycobacterial antigens (42) but also recall antigens like keyhole limpet hemocyanin (42). In addition, a contribution of CD4+ and CD8+ T cells to acquired resistance to M. bovis has been suggested to occur in knockout mice deficient for major histocompatibility complex molecules (26).
Resistance or susceptibility to mycobacterial infection could be related to an inappropriate induction of T-cell tolerance caused by the dysregulation of physiological cell death programs (1, 47). Apoptosis may play a major role in the suppression of Th-1-dependent effector functions occurring during various infectious diseases (1, 14). Activation-induced cell death (AICD) has been reported to be dependent on the interactions between ligands and receptors belonging to the tumor necrosis factor (TNF) family, which includes TNF and Fas (35), and on the susceptibility of the cells to receptor-mediated death signal transduction (23). These death-triggering pathways are involved in the elimination of antigen-stimulated peripheral T cells to terminate an immune response and to limit inflammation (31, 45, 56). It has also been reported that such molecules may play a major role during human immunodeficiency virus (HIV) infection (12, 13, 19) and participate in Peyer's patch T-cell death in mice infected with Toxoplasma gondii (29).
We report here that a defect of T-cell proliferation in response to mitogen or anti-CD3 antibody in C57BL/6 and BALB/c (bcgs) mice but not in DBA/2 and C3H/HeJ (bcgr) mice after infection with M. bovis BCG is associated with the induction of both CD4+ and CD8+ T-cell apoptosis.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Mouse strains.
C57BL/6 (Nramp1
), BALB/c
(Nramp1
), C3H/HeJ (Nramp1+), and DBA/2
(Nramp1+) mice were purchased from Janvier (Le Genest, St
Isle, France); 6-week-old animals were used for primary infection.
BCG infection. Mice were inoculated in the retroorbital vein with 5 × 106 CFU of M. bovis BCG (vaccine strain 1173P2; World Health Organization, Stockholm, Sweden) freshly grown on Sauton medium (43). The mice were sacrificed 2 to 3 weeks later.
Antibodies and reagents.
Rat anti-mouse
phycoerythrin-conjugated Thy-1.2 (53-2.1), rat anti-mouse
Cy-chrome-conjugated B220 (RA3-6B2), rat anti-mouse Cy-chrome-conjugated CD4 (RM4-5), rat anti-mouse Cy-chrome-conjugated CD8 (53-6.7), fluorescein isothiocyanate (FITC)-conjugated hamster anti-mouse Fas (Jo2), rat anti-mouse TNF-
(MP6-XT3), rat
immunoglobulin G1 (IgG1) isotype control (R3-34), and hamster
anti-mouse CD3 (145-2C11) were purchased from Pharmingen (San Diego,
Calif.). The hybrid protein containing the Fc portion of mouse IgG1 and the recombinant Fas antigen (Fas-Fc) was purchased from Alexis Corp.
(San Diego, Calif.). Other reagents were staphylococcal enterotoxin B
(Toxin Technology Inc., Madison, Wis.), concanavalin A (ConA), pokeweed
M, and acridine orange dye (Immunotech, Marseille, France).
Cell culture conditions.
T cells from uninfected and
infected mice were prepared from spleen using Lympholyte-M (Cedar Lane,
Hornby, Ontario, Canada) density gradient centrifugation. B cells were
depleted by incubating the cell suspensions at 4°C for 45 min with
magnetic beads coated with goat anti-mouse IgG. Ig-positive cells were
then removed using a magnetic concentrator (Immunotech). For C57BL/6,
BALB/c, C3H/HeJ, and DBA/2, the T-cell purity was 92, 90, 80, and 92%, respectively. Cells were cultured in RPMI 1640 (Gibco, Courbevoie, France) supplemented with 10% heat-inactivated fetal calf serum (Boehringer Mannheim, Meylan, France), 100 U of penicillin (Gibco) per
ml, 20 µg of streptomycin (Gibco) per ml, 2 mM
L-glutamine, 5 × 10
5 M
-mercaptoethanol (Merck, Darmstadt, Germany), and 1 mM sodium pyruvate (Gibco).
T-cell proliferation. T cells were cultured at a concentration of 5 × 104 cells/well in 96-well flat-bottom culture plates (Falcon, Becton Dickinson, Mountain View, Calif.) in the absence or presence of one of the following stimuli: 1 µg of ConA per ml, or 10 µg of anti-CD3 per ml. Each proliferation test was performed in triplicate. Cultures were incubated at 37°C in a humidified CO2 incubator for 3 days and then pulse-labeled with 1 µCi of [3H]thymidine (Amersham, Les Ulis, France). Cells were then harvested onto fiber filter strips using a multiharvester (Skatron, Lierbyen, Norway), and the incorporated radioactivity was determined by liquid scintillation counting (LKB, Wallac, Turku, Finland).
Apoptosis measurement. Apoptosis was measured in vitro by three different methods. (i) Using the light microscope, the cells counted as apoptotic included cells with characteristic nuclear chromatin condensation and fragmentation, as well as already dead cells that had lost the trypan blue exclusion capacity, as previously described (11, 25). (ii) Using flow cytometry (FCM) analysis (FACScan; Becton Dickinson) after incubation of the cells with acridine orange nuclear dye (0.1 µg/ml) for 2 min, as described previously (11), apoptosis was detected by observing a distinct peak of reduced fluorescence intensity. (iii) Cells undergoing apoptosis were also identified by FCM using FITC-conjugated annexin V (R&D Systems, Abingdon, United Kingdom), a phospholipid-binding protein (50). This method was used to detect apoptotic T-cell subpopulations. T cells were first stained by being incubated with rat anti-mouse Cy-chrome-conjugated CD4 or rat anti-mouse Cy-chrome-conjugated CD8 antibodies, washed with phosphate-buffered saline, and then incubated in binding buffer with FITC-annexin V for 20 min at 4°C, as specified by the manufacturer (Immunotech). The cells were analyzed by FCM analysis.
Apoptosis was assessed in tissue sections by the terminal deoxytransferase (TdT)-mediated dUTP nick end labeling (TUNEL) method. Briefly, microscopy analysis of in situ DNA fragmentation was assessed on 5-µm paraffin sections of formalin-fixed spleens and livers. Tissue sections were washed once with TdT buffer (Gibco) and then incubated with 0.5 µM digoxigenin-dUTP and 5 U of TdT (Boehringer Mannheim), in 30 to 50 µl of TdT buffer. The sections were incubated for 1 h at 37°C and then washed in PBS. A sheep anti-digoxigenin-alkaline phosphatase-conjugated antibody (Boehringer Mannheim) was next added for 40 min at 37°C and revealed with naphthol AS-MX, Fast Red, and levamisol. The sections were counterstained with Harris hematoxylin and mounted with gelatin.Fas expression. Fas expression was assessed on T cells by double labeling using anti-mouse Cy-chrome-conjugated CD4 and anti-mouse Cy-chrome-conjugated CD8 antibodies, as well as the anti-mouse FITC-conjugated Fas antibodies. The cells were incubated for 30 min at 4°C, washed twice, and then analyzed by FCM.
RNA extraction and RT-PCR analysis.
Total RNA was extracted
from T cells using RNAzol (Bioprobe, Montreuil, France) as recommended
by the manufacturer. For each sample, equal amounts of total RNA (1 µg) were reverse transcribed with 200 U of Moloney murine leukemia
virus reverse transcriptase (RT; Gibco BRL, Eragny, France), 4 U of
RNasin (Promega, Lyon, France), 50 ng of oligo(dT), 2 mM each
deoxynucleoside triphosphate, and 4 mM dithiothreitol in a final volume
of 27 µl. The products were then denatured by heating at 95°C
before being stored at
20°C. PCR amplification was performed using
primers for
-actin (5'-GTG GGG CGC CCC AGG CAC CA-3' and 5'-CTT TAG
CAC GCA CTG TAA TTC CTC-3'), and FasL (5'-CAG CTC TTC CAC CTG CAG AAG
G-3' and 5'-AGA TTC CTC AAA ATT GAT CAG AGA GAG-3'). The cDNA samples
were amplified using a DNA thermal cycler (Perkin Elmer Cetus,
Saint-Quentin, France) for 35 cycles for
-actin and FasL at an
annealing temperature of 55°C for FasL and of 60°C for
-actin.
For each cDNA preparation, a control reaction was performed without RT
to ensure that there was no contaminating genomic DNA. The PCR products
were analyzed by agarose gel electrophoresis (1.5% agarose) in TBE
(0.09 M Tris borate, 0.002 M EDTA [pH 8.0]) containing ethidium
bromide (25 µg/50 ml of gel).
TNF-
assay.
Mouse TNF-
activity present in the sera
collected by retroorbital puncture was determined at several time
points after BCG infection from individual mice, using the Factor-test
mouse TNF-
enzyme-linked immunosorbent assay (ELISA) kit (Genzyme,
Cambridge, Mass.). Results are expressed as picograms per milliliter
and are means of duplicate assays.
Statistical analysis. The statistical significance (P) was assessed using Student's t test.
| |
RESULTS |
|---|
|
|
|---|
BCG-induced splenomegaly.
As shown in Fig.
1, infection of C57BL/6 and C3H/HeJ mice
with BCG resulted in strong splenomegaly, which was more pronounced in
C57BL/6 mice than in C3H/HeJ mice, as judged by macroscopic examination
of the organs (Fig. 1A). This was confirmed by weighing the spleens of
infected and uninfected animals. Although the spleens of the two mouse
strains had similar weights when the animals were not infected (about
80 to 100 mg), infection with BCG resulted in an approximately
threefold increase in the weight of C3H/HeJ spleens and in an eightfold
increase in the weight of C57BL/6 spleens (data not shown). Similarly,
in two additional mouse strains, BALB/c (bcgs) and DBA/2
(bcgr), BCG infection induced a splenomegaly more
pronounced in BALB/c than in DBA/2 mice (data not shown). Subpopulation
analysis indicated that BCG infection induced a major B-cell
proliferation in the C57BL/6 mice, in contrast to C3H/HeJ mice (Fig.
1B). Moreover, the splenic architecture was largely disorganized in
infected C57BL/6 mice, as assessed by histological analysis (Fig.
2A). Microscopic examination of the liver
also revealed that infected C57BL/6 mice had a more pronounced cellular
infiltration than did infected C3H/HeJ mice (Fig. 2B). These results
suggest a more general immune activation associated with strong
inflammation in infected susceptible mice than in infected resistant
mice.
|
|
T-cell apoptosis related to susceptibility.
Defective T-cell
proliferation during mycobacterium infection has been previously
reported (42). The T-cell proliferation in the two mouse
strains was therefore assessed. T cells were isolated by negative
selection from the spleens of C57BL/6 and C3H/HeJ mice infected or not
infected with 5 × 106 CFU of viable BCG. As shown in
Fig. 3A, T cells from infected C3H/HeJ
mice displayed similar polyclonal activation to those isolated from the
uninfected mice. In contrast, the T-cell proliferation of C57BL/6 mice
was considerably depressed after BCG infection.
|
) and DBA/2
(bcgr, Nramp1+), and in vitro analysis
indicated that although BCG infection enhances spontaneous T-cell death
(Fig. 4A), only T cells from BALB/c
undergo apoptosis after T-cell stimulation (Fig. 4B). Moreover, stimulation of T cells using monoclonal antibody to the T-cell receptor-CD3 complex induced a decrease in thymidine incorporation (cell proliferation) (Fig. 5A), a
decrease in T-cell numbers (viable cells) (Fig. 5B), and an increased
incidence of cell death (Fig. 5C) after 3 days of culture in infected
C57BL/6 mice in comparison to uninfected C57BL/6 mice and to both
infected and uninfected C3H/HeJ mice. Together, these results suggest
that the depressed T-cell proliferation observed above for BCG-infected
C57BL/6 mice may be related to an increased susceptibility to apoptosis
rather than to a process of anergy only. At 2 weeks after BCG
infection, priming of a large fraction of splenic T cells for AICD was
associated in vivo with numerous cells undergoing apoptosis in the
spleen (Fig. 6A) and in liver infiltrates
(Fig. 6B and C) in C57BL/6 mice in comparison to C3H/HeJ mice, as
detected by in situ analysis of fragmented DNA using the TUNEL method.
|
|
|
TNF-
production.
Next, we investigated whether the C3H/HeJ
and C57BL/6 mouse strains differ in TNF-
production after BCG
infection. The kinetics of TNF-
secretion from serum were assessed
by ELISA from a pool of four sera (Fig.
7A) and from individual mice (Fig. 7B).
High levels of TNF-
were detected only in the serum of C57BL/6 mice infected with BCG (Fig. 7). TNF-
production increased progressively, peaked 12 days after infection, and then started to decline. Only small
amounts of TNF-
were detected in C3H/HeJ mice infected with BCG, and
no TNF-
was detected in uninfected animals of either strain.
|
Fas-FasL expression.
Fas expression was assessed by FCM on
splenocytes isolated from infected and uninfected C3H/HeJ and C57BL/6
mice. Total splenocytes from BCG-infected C3H/HeJ mice expressed
slightly higher levels of Fas than did splenocytes of uninfected
C3H/HeJ mice, whereas BCG infection of C57BL/6 mice enhanced Fas
expression much more strongly (data not shown). Analysis of T-cell
subpopulations revealed that increased Fas expression was detected in
both CD4+ and CD8+ T-cell populations 2 weeks
after infection with BCG (Fig. 8). Again,
the difference between infected and uninfected mice was much more
pronounced for the C57BL/6 strain than for the C3H/HeJ strain. To
investigate whether the controlling events of apoptosis involve changes
in FasL expression, RT-PCR was performed on total RNA from T cells of
both infected and uninfected mice. Figure 9 shows that FasL mRNA was similar
in uninfected and in BCG-infected C57BL/6 mice. However, FasL
expression, which was high in uninfected C3H/HeJ mice, decreased upon
infection.
|
|
Involvement of Fas and TNF-
in activation-induced T-cell death
in BCG-infected C57BL/6 mice.
Since both TNF-
and Fas were
expressed at higher levels in infected C57BL/6 mice than in infected
C3H/HeJ mice, we examined whether these factors participate in the
regulation of activation-induced T-cell death. The contribution of
TNF-
and FasL to AICD following BCG infection was determined by
using purified T cells incubated for 18 h in the presence or
absence of neutralizing anti-TNF-
antibodies and of antagonistic Fas
antibodies (Fas-Fc protein). T-cell depletion was assessed by FCM using
FITC-conjugated annexin V labeling that detects apoptotic cells in each
of the T-cell subpopulations studied. The addition of Fas-Fc prevented
the death of CD4+ T cells from infected C57BL/6 mice,
whereas apoptosis of the CD8+ T cells from these mice
remained unaffected (Fig. 10). The
anti-TNF-
antibodies inhibited apoptosis of both CD8+ T
cells and CD4+ T cells from the infected C57BL/6 mice.
Together, these results suggest that TNF-
and FasL participate in
the control of T-cell apoptosis.
|
| |
DISCUSSION |
|---|
|
|
|---|
In this study, we show that BCG susceptibility is associated with
T-cell apoptosis. Our data suggest that in susceptible mouse strains
(C57BL/6 and BALB/c) a defect in in vitro T-cell proliferation after
mitogen or TCR restimulation involves apoptosis and that this depressed
cell-mediated immunity (CMI) was not observed in BCG-resistant mouse
strains (C3H/HeJ and DBA/2). In addition, further investigations with
C57BL/6 and C3H/HeJ mice suggest that activation-mediated T-cell
apoptosis in infected C57BL/6 mice involved mainly TNF-
and
Fas-FasL.
T-cell apoptosis is considered to be an important regulatory mechanism of the immune response and is involved in the loss of effector functions during infectious diseases. Recent studies reported that infection with the protozoan parasites Trypanosoma cruzi and Toxoplasma gondii leads to a downregulation of the CMI associated with the induction of CD4+ T-cell apoptosis (21, 30). In Schistosoma mansoni-infected mice, the immunopathologic granulomatous response to parasite eggs, which is associated with a global functional defect in CMI, is also related to a CD4+ and CD8+ T-cell apoptotic process (1, 14). Xu et al. (54) have reported a drastic depletion of CD3+ T cells in susceptible but not in resistant mice at the final stage of infection with Mycobacterium avium. During the preparation of our manuscript, Das et al. (8) reported that M. tuberculosis infection of a susceptible host results in the abnormal death of CD4+ T cells after in vitro stimulation. Together with our observations, these results suggest that mycobacteria are able to trigger death by apoptosis. Nevertheless, no apparent net depletion in T lymphocytes was observed in susceptible mice, suggesting a compensatory reconstitution of dying cells, with a T-cell turnover. Such turnover of T cells in the absence of depletion has been reported to occur in CD8+ T cells during the asymptomatic phase of HIV infection in humans and in nonhuman primates (39, 41, 53). The Nramp1 gene product controls the innate resistance and susceptibility of macrophages to microorganisms (15, 51). Although Nramp1 has been clearly associated in the control of M. bovis, less evidence for a role in the control of M. tuberculosis and M. avium has been demonstrated (33). Our observation suggest that at least in two resistant and two susceptible mouse strains, a segregation between the Nramp1 gene and apoptosis is observed.
The expression of a family of ligands (TNF-
and FasL) and receptors
(TNF receptor and Fas), as well as the induction of susceptibility of
these cells to receptor-initiated signals, has been involved in the
process of T-cell apoptosis (35). We suggested a pivotal role for TNF-
during BCG infection of C57BL/6 mice. First, our observation indicates an important TNF-
production in the sera of
infected C57BL/6 mice but not of C3H/HeJ mice; second, neutralizing antibodies to TNF-
prevent CD3-mediated CD4+ and
CD8+ T-cell apoptosis. Moreover, this TNF-
production
coincides with an important inflammatory response characterized by
intense cellular infiltrates in the livers of these mice and
destruction of the architecture of the spleen. The TUNEL method
revealed the presence of a large number of apoptotic cells in the liver
infiltrates in C57BL/6 mice compared to the number in C3H/HeJ mice.
Kindler et al. (22) have shown that injection of
anti-TNF-
antibodies into mice infected with BCG strongly interferes
with the development of granulomas and that TNF-
is central in the
formation of BCG-induced granulomas. Doherty and Sher (9)
have also recently shown that 2 weeks after infection with M. avium the mitogen response of C57BL/6 mice was clearly suppressed
compared to that of uninfected mice. Using TNF-
receptor-deficient
mice, they showed the importance of TNF-
in this immunosuppression.
Additionally, the splenomegaly of these knockout mice was greatly
diminished. Although immunopathology was strongly reduced in these
mice, no increase in the control of M. avium bacterial
growth was observed (9). Nevertheless, a recent report by
Ehlers et al. (10) indicated, in contrast, that TNF receptor
p55 gene-deficient mice develop granulomas that become necrotic and
cause tissue damage following M. avium infection. Thus,
apoptosis would be involved in restricting rather than exacerbating the
inflammatory response. Therefore, whether TNF-
-mediated apoptosis during BCG or other mycobacterial infections in susceptible hosts only
participates in immunopathology or alters the effectiveness of
immune-mediated control of the bacterial load remains to be assessed.
In tuberculosis patients, blood monocytes (46) and alveolar
macrophages (40) release TNF-
in large quantities, and
this cytokine is also present in tuberculous lesions (5). Recent data indicate that enhanced levels of apoptosis occur during active M. tuberculosis infection in human (16).
Thus, spontaneous apoptosis and AICD are increased in both
CD4+ and CD8+ T cells of newly diagnosed
tuberculosis-infected persons over those in healthy subjects. Culture
supernatants show the presence of abnormal levels of TNF-
and
soluble Fas molecules in these patients.
Our results demonstrate that BCG infection increases the proportions of
both CD4+ and CD8+ T cells expressing Fas in
both C57BL/6 and C3H/HeJ mouse strains, compared to uninfected mice.
However, the percentage of T cells, and in particular of
CD4+ T cells, expressing Fas was significantly higher in
C57BL/6 than in C3H/HeJ mice. We also found that level of FasL mRNA was
not affected upon BCG infection in C57BL/6 mice whereas the level of
FasL mRNA, which was more abundant in the uninfected C3H/HeJ mice than
in the uninfected C57BL/6 mice, decreased drastically upon BCG
infection in this mouse strain. However, our data indicate that
Fas-FasL participates in AICD of CD4+ T cells but not in
that of CD8+ T cells in C57BL/6 mice. At this time, we
cannot generalize those mechanisms to all mouse strains. Although we
observed that C57BL/6 and BALB/c mice are equaly susceptible to AICD
when infected with BCG, it should be noted that these two strains of
mice differ in their resistance and susceptibility to leishmania, being
considered Th1 and Th2 models of the immune response to infection,
respectively (28). Therefore, it is possible that in the
context of BCG infection, several mechanisms in addition to TNF-
and
FasL may also operate in different mouse strains involving certain
cytokines like TGF-
and IL-10, which have been reported to
participate in AICD in other models of infection (12-14).
Moreover, although both TNF-
- and Fas-mediated apoptosis contribute
to the death of T lymphocytes in C57BL/6 mice, additional mechanisms
could also participate in T-cell apoptosis. The in vitro prevention of
T-cell apoptosis using neutralizing antibodies to TNF-
and Fas was
not complete, suggesting the potential involvement of other pathways of
T-cell depletion. Other recently described ligands, like the
TNF-related apoptosis-inducing ligand (TRAIL), a new member of the TNF
family which has been recently shown to trigger AICD in HIV-infected individuals, could play a role (20). However, whether TRAIL or any other death factor is involved in T-cell death during
mycobacterial infections requires further investigation.
The precise mechanisms by which mycobacteria induce T-cell apoptosis
and the bacterial components responsible remain to be elucidated. Ozeki
et al. (37) have demonstrated that the mycobacterial cord
factor induces apoptosis in the mouse thymus in vivo. However, nothing
is known about the potential involvement of cord factor in the
induction of apoptosis in mature T cells. Evidence has also emerged
suggesting that monocyte-derived macrophages acquire the ability to
selectively induce apoptosis of T cells in an activation-specific fashion (34). Badley et al. (2, 3) have reported
that upregulation of FasL expression by HIV in human macrophages
mediates apoptosis of uninfected T lymphocytes and may therefore
participate in T-cell depletion in HIV-infected individuals. Since
mycobacteria are able to invade phagocytic cells but not lymphocytes,
it is tempting to postulate a similar scenario for mycobacterial
infections. In this regard, it has been previously reported that both
whole organisms and antigens derived from M. bovis and
M. tuberculosis induced the production of TNF-
from
monocytes (4, 49, 52, 55). Thus, activated macrophages could
then provide an important source of TNF-
and/or FasL, which may
participate in T-cell depletion and therefore in immunosuppression.
However, the role of Fas-FasL in host-pathogen interactions may be
complex, since recent data have shown that resolution of lesions
induced by Leishmania major in mice was dependent on a
functional Fas pathway that was responsible for the apoptosis of
infected macrophages (6).
Finally, taken together, our results suggest that induction of apoptosis in both CD4+ and CD8+ T-cell subsets may contribute to mycobacterium-mediated immune dysregulation in susceptible hosts.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by Institut Pasteur de Lille, INSERM, Région Nord-Pas de Calais, and the EC Biotech program. J.E. was supported by the Human Science Frontier Program and ANRS.
L.K. and J.E. contributed equally to this work.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: INSERM E9922, Groupe Hospitalier Bichat-Claude Bernard, 16 rue Henri Huchard, 75018 Paris, France. Phone: (33) 1 44 85 62 88. Fax: (33) 1 44 85 62 88. E-mail: estaquie{at}bichat.inserm.fr.
Present address: Department of Microbiology and Immunology, The
Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne
NE2 4HH, United Kingdom.
Editor: S. H. E. Kaufmann
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ameisen, J.-C., J. Estaquier, and T. Idziorek. 1994. From AIDS to parasite infection: pathogen-mediated subversion of programmed cell death as a mechanism for immune dysregulation. Immunol. Rev. 142:9-51[CrossRef][Medline]. |
| 2. | Badley, A. D., J. A. McElhinny, P. J. Leibson, D. H. Lynch, M. R. Alderson, and C. V. Paya. 1996. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol. 70:199-206[Abstract]. |
| 3. |
Badley, A. D.,
D. Dockrell,
M. Simpson,
R. Schut,
D. H. Lynch,
P. Leibson, and C. V. Paya.
1997.
Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor.
J. Exp. Med.
185:55-64 |
| 4. | Barnes, P., D. Chatterjee, J. Abrams, S. Lu, E. Wang, M. Yamamura, P. Brennan, and R. Modlin. 1992. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. J. Immunol. 149:541-547[Abstract]. |
| 5. |
Barnes, P. F.,
S. J. Fong,
P. J. Brennan,
P. E. Twomey,
A. Mazumder, and R. L. Modlin.
1990.
Local production of tumor necrosis factor and IFN- in tuberculous pleuritis.
J. Immunol.
145:149-154[Abstract].
|
| 6. | Conceicao-Silva, F., M. Hahne, M. Schröter, L. Louis, and J. Tschopp. 1998. The resolution of lesions induced by Leishmania major in mice requires a functional Fas (APO-1, CD95) pathway of cytotoxicity. Eur. J. Immunol. 28:237-245[CrossRef][Medline]. |
| 7. | Daniel, T. M., M. J. Oxtoby, E. Pinto, and S. Moreino. 1981. The immune spectrum in patients with pulmonary tuberculosis. Am. Rev. Respir. Dis. 123:556-559[Medline]. |
| 8. | Das, G., H. Vohra, B. Saha, J. N. Agrewala, and G. C. Mishra. 1999. Apoptosis of Th1-like cells in experimental tuberculosis (TB). Clin. Exp. Immunol. 115:324-328[CrossRef][Medline]. |
| 9. | Doherty, T. M., and A. Sher. 1997. Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection. J. Immunol. 158:4822-4831[Abstract]. |
| 10. |
Ehlers, S.,
J. Benini,
S. Kutsch,
R. Endres,
E. Rietschel, and K. Pfeffer.
1999.
Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium.
Infect. Immun.
67:3571-3579 |
| 11. |
Estaquier, J.,
T. Idziorek,
F. De Bels,
F. Barré-Sinoussi,
B. Hurtrel,
A. M. Aubertin,
A. Venet,
M. Mehtali,
E. Muchmore,
P. Michel,
Y. Mouton,
M. Girard, and J.-C. Ameisen.
1994.
Programmed cell death and AIDS: the significance of T-cell apoptosis in pathogenic and non pathogenic primate lentiviral infections.
Proc. Natl. Acad. Sci. USA
91:9431-9435 |
| 12. |
Estaquier, J.,
T. Idziorek,
W. Zou,
D. Emilie,
C. M. Farber,
J. M. Bourez, and J.-C. Ameisen.
1995.
T helper type 1/T helper type 2 cytokines and T-cell death: preventive effect of IL-12 on activation-induced and CD95 (Fas/Apo-1)-mediated apoptosis of CD4+ T cells from HIV-infected persons.
J. Exp. Med.
182:1759-1767 |
| 13. |
Estaquier, J.,
M. Tanaka,
T. Suda,
S. Nagata,
P. Golstein, and J.-C. Ameisen.
1996.
Fas-mediated apoptosis of CD4+ and CD8+ T cells from HIV-infected persons: differential in vitro preventive effect of cytokines and protease antagonists.
Blood
87:4959-4966 |
| 14. | Estaquier, J., M. Marguerite, F. Sahuc, N. Bessis, C. Auriault, and J.-C. Ameisen. 1997. Interleukin-10-mediated T cell apoptosis during the T helper type 2 cytokine response in murine Schistosoma mansoni parasite infection. Eur. Cytokine Netw. 8:153-160[Medline]. |
| 15. | Govoni, G., and P. Gros. 1998. Macrophage NRAMP1 and its role in resistance to microbial infections. Inflamm. Res. 47:277-284[CrossRef][Medline]. |
| 16. | Hirsch, C. S., Z. Toossi, G. Vanham, J. L. Johnson, P. Peters, A. Okwera, R. Mugerwa, P. Mugyenyi, and J. J. Ellner. 1999. Apoptosis and T cell hyporesponsiveness in pulmonary tuberculosis. J. Infect. Dis. 179:945-953[CrossRef][Medline]. |
| 17. | Holden, M., M. R. Dubin, and P. H. Diamond. 1971. Frequency of negative intermediate-strength tuberculin sensitivity in patients with active tuberculosis. N. Engl. J. Med. 285:1506-1509. |
| 18. | Kaledin, V. I., Y. N. Kurunov, and I. A. Serova. 1977. Inhibition and stimulation of the growth of Krebs-2 carcinoma by BCG vaccine. J. Natl. Cancer Inst. 58:1271-1277. |
| 19. |
Katsikis, P. D.,
E. S. Wunderlich,
C. A. Smith, and L. A. Herzenberg.
1995.
Fas antigen stimulation induces marked apoptosis of T lymphocytes in HIV-infected individuals.
J. Exp. Med.
181:2029-2036 |
| 20. |
Katsikis, P. D.,
M. E. Garcia-Ojeda,
J. F. Torres-Roca,
I. M. Tijoe,
C. A. Smith, and L. A. Herzenberg.
1997.
Interleukin-1 converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection.
J. Exp. Med.
186:1365-1372 |
| 21. |
Khan, I. A.,
T. Matsura, and L. H. Kasper.
1996.
Activation-mediated CD4+ T-cell unresponsiveness during acute Toxoplasma gondii infection in mice.
Int. Immunol.
8:887-896 |
| 22. | Kindler, V., A. P. Sappino, G. E. Grau, P. F. Piguet, and P. Vassali. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731-740[CrossRef][Medline]. |
| 23. |
Klas, C.,
K. M. Debatin,
R. R. Jonker, and P. H. Krammer.
1993.
Activation interferes with the APO-1 pathway in mature human T cells.
Int. Immunol.
5:625-630 |
| 24. | Kleinhenz, M. E., and J. J. Ellner. 1987. Antigen responsiveness during tuberculosis: regulatory interaction of T-cell subpopulations and adherent cells. J. Lab. Clin. Med. 110:31-40[Medline]. |
| 25. | Kremer, L., J. Estaquier, E. Brandt, J.-C. Ameisen, and C. Locht. 1997. Mycobacterium bovis bacillus Calmette Guérin infection prevents apoptosis of resting human monocytes. Eur. J. Immunol. 27:2450-2456[Medline]. |
| 26. | Ladel, C. H., S. Daugelat, and S. H. E. Kaufmann. 1995. Immune response to Mycobacterium bovis Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance. Eur. J. Immunol. 25:377-384[Medline]. |
| 27. | Lagrange, P. H., and B. Hurtrel. 1979. The influence of BCG vaccination on murine leprosy in C57BL/6 and C3H mice. Ann. Immunol. (Paris) 130C:687-709. |
| 28. | Launois, P., F. Tacchini-Cottier, C. Parra-Lopez, and J. A. Louis. 1998. Cytokines in parasitic diseases: the example of cutaneous leishmaniasis. Int. Rev. Immunol. 17:157-180[Medline]. |
| 29. | Liesenfeld, O., J. C. Kosek, and Y. Suzuki. 1997. Gamma interferon induces Fas-dependent apoptosis of Peyer's patch T cells in mice following peroral infection with Toxoplasma gondii. Infect. Immun. 65:4682-4689[Abstract]. |
| 30. | Lopes, M. F., V. F. da Veiga, A. R. Santos, M. E. Fonseca, and G. A. Dos-Reis. 1995. Activation-induced CD4+ T-cell death by apoptosis in experimental Chagas' disease. J. Immunol. 154:744-752[Abstract]. |
| 31. | Lynch, D., H. F. Ramsdell, and M. R. Alderson. 1995. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 12:569-574. |
| 32. | Masen, U. G., III, L. E. Greenberg, S. S. Yen, and C. H. Kirkpatrick. 1982. Indomethacin-responsive mononuclear cell dysfunction in "atypical" mycobacteriosis. Cell. Immunol. 71:54-65[CrossRef][Medline]. |
| 33. |
Medina, E., and R. North.
1996.
Evidence inconsistent with a role for the BCG gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium tuberculosis.
J. Exp. Med.
183:1045-1051 |
| 34. | Munn, D. H., J. Pressey, A. C. Beall, R. Hudes, and M. R. Alderson. 1996. Selective activation-induced apoptosis of peripheral T cells imposed by macrophages. J. Immunol. 156:523-532[Abstract]. |
| 35. |
Nagata, S., and P. Golstein.
1995.
The Fas death factor.
Science
267:1449-1456 |
| 36. | Orme, I. M., P. Andersen, and W. H. Boon. 1993. T cell response to Mycobacterium tuberculosis. J. Infect. Dis. 167:1481-1497[Medline]. |
| 37. | Ozeki, Y., K. Kaneda, N. Fujiwara, M. Morimoto, S. Oka, and I. Yano. 1997. In vivo induction of apoptosis in the thymus by administration of mycobacterial cord factor (trehalose-6,6'-dimycolate). Infect. Immun. 65:1793-1799[Abstract]. |
| 38. | Pelletier, M., A. Forget, D. Bourassa, P. Gros, and E. Skamene. 1982. Immunopathology of BCG infection in genetically resistant and susceptible mouse strains. J. Immunol. 129:2179-2185[Abstract]. |
| 39. | Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586[Abstract]. |
| 40. | Rook, G. A. W., and R. Al Attiyah. 1991. Cytokines and the Koch phenomenon. Tubercle 72:13-20[CrossRef][Medline]. |
| 41. |
Sachsenberg, N.,
A. S. Perelson,
S. Yerly,
G. A. Schockmel,
D. Leduc,
B. Hirschel, and L. Perrin.
1998.
Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen.
J. Exp. Med.
187:1295-1303 |
| 42. | Saha, B., G. Das, H. Vohra, N. K. Ganguly, and G. C. Mishra. 1994. Macrophage-T cell interaction in experimental mycobacterial infection. Selective regulation of co-stimulatory molecules on Mycobacterium-infected macrophages and its implication in the suppression of cell-mediated immune response. Eur. J. Immunol. 24:2618-2624[Medline]. |
| 43. | Sauton, M. B. 1912. Sur la nutrition minérale du bacille tuberculeux. C. R. Acad. Sci. 155:860-861. |
| 44. | Skamene, E., P. Gros, A. Forget, P. A. Kongshavn, C. St. Charles, and B. A. Taylor. 1982. Genetic regulation of resistance to intracellular pathogens. Nature 297:506-509[CrossRef][Medline]. |
| 45. | Sytwu, H.-K., R. S. Liblau, and H. O. McDewitt. 1996. The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5:17-30[CrossRef][Medline]. |
| 46. |
Takashima, T.,
C. Ueta,
I. Tsuyuguchi, and S. Kishimoto.
1990.
Production of tumor necrosis factor alpha by monocytes from patients with pulmonary tuberculosis.
Infect. Immun.
58:3286-3292 |
| 47. |
Thompson, C. B.
1995.
Apoptosis in the pathogenesis and treatment of disease.
Science
267:1456-1462 |
| 48. |
Toossi, Z.,
M. E. Kleinhenz, and J. J. Ellner.
1986.
Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis.
J. Exp. Med.
163:1162-1172 |
| 49. |
Valone, S.,
E. Rich,
R. Wallis, and J. Ellner.
1988.
Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens.
Infect. Immun.
56:3313-3315 |
| 50. | Vermes, I., C. Haanen, H. Steffens-Nakken, and C. Reutelingsperger. 1995. A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J. Immunol. Methods 184:39-51[CrossRef][Medline]. |
| 51. | Vidal, S., D. Malo, K. Vogan, E. Skamene, and P. Gros. 1993. Natural resistance to infection with intracellular parasites: identification of a candidate gene for BCG. Cell 73:469-485[CrossRef][Medline]. |
| 52. |
Wallis, R.,
R. Paranjape, and M. Philips.
1993.
Identification by two dimensional gel electrophoresis of a 58-kilodalton tumor necrosis factor-inducing protein of Mycobacterium tuberculosis.
Infect. Immun.
61:627-633 |
| 53. |
Wolthers, K. C.,
G. Bea,
A. Wisman,
S. A. Otto,
A. M. de Roda Husman,
N. Schaft,
F. de Wolf,
J. Goudsmit,
R. A. Coutinho,
A. G. van der Zee,
L. Meyaard, and F. Miedema.
1996.
T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover.
Science
274:1543-1547 |
| 54. | Xu, D. L., Y. Goto, K. K. Amoako, T. Nagatomo, K. Uchida, and T. Shinjo. 1995. Immune responsiveness in Mycobacterium avium-infected mice: changes in the proportion of T cell subsets and antibody production during the course of infection. Clin. Exp. Immunol. 102:523-528[Medline]. |
| 55. |
Zhang, Y.,
M. Doerfler,
C. Theodore,
B. Guillemein, and W. Rom.
1993.
Mechanisms of stimulation of interleukin-1 and tumor necrosis factor- by mycobacterium tuberculosis components.
J. Clin. Investig.
91:2076-2083.
|
| 56. | Zheng, L., G. Fisher, R. E. Miller, J. Peschon, D. H. Lynch, and M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377:348-351[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||